In early 2016, Rodger Currie returned to the Pharmaceutical Research and Manufacturers of America (PhRMA) as Executive Vice President for Advocacy to lead the federal, state, international, and alliance departments reporting to President & CEO Steve Ubl. He has a long record of working across party lines and collaborating with stakeholders throughout the healthcare sector. For more than 10 consecutive years, The Hill newspaper named Currie a top lobbyist.
Currie previously served from 1998-2004 as PhRMA’s Senior Vice President for Government Affairs and Law (2001-2004), Vice President for Government Affairs and Law (2000), Vice President for Law (1999), and Assistant General Counsel (1998). He led all aspects of PhRMA’s successful multi-year effort to support the development and passage of the historic “Medicare Prescription Drug, Improvement, and Modernization Act of 2003” (Public Law 108-173), the law that created the Medicare Part D drug benefit and represented the largest overhaul of Medicare in the public health program’s history.
Currie then served as Vice President of Global Government Affairs for Amgen, a PhRMA member company and the largest biotechnology company in the world, from 2004-2010. At Amgen, he built and led the team that ensured patient access to 4 of the top 10 Medicare Part B drugs and led Amgen’s effort to support the development and passage of the landmark “Biologics Price Competition and Innovation Act of 2009” (Public Law 111-148). The 2009 Act created an approval pathway for biosimilar biological products and guaranteed 12 years of exclusivity for the innovative reference medicine.
Prior to his original tenure at PhRMA, Currie had the privilege of working as Majority Health Counsel to the U.S. House Committee on Energy & Commerce where he advised the Committee Chairman and House Republican Leadership on Federal and State health insurance programs. Currie was responsible for all phases of the development of policy proposals and the passage of legislation, including the regulation of private and public health insurance and the enactment of the Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) provisions of the famed “Balanced Budget Act” (Public Law 105-33) – the omnibus budget reconciliation bill that balanced the federal budget by enacting $160 billion in spending reductions between 1998 and 2002. Currie was also Counsel of Record for all aspects of the landmark “FDA Modernization Act” (Public Law 105-115) that modernized FDA regulation of drug and biological products, streamlined the development process for new medicines, and cut approval times in half through the reauthorization of the “Prescription Drug User Fee Act” (PDUFA II).
Currie also served as Chief of Government Affairs for the physician leaders at the American Psychiatric Association where he developed a passion for the importance of improving mental health and substance use treatment. A lawyer, Currie was an associate at the healthcare law firm of Fox, Bennett, and Turner prior to working on Capitol Hill and later worked as a partner to legendary healthcare advocate Nick Littlefield at the law firm of Foley Hoag.
Currie earned B.A. and J.D. degrees from Georgetown University. He is a member of both the Massachusetts and DC bar associations and currently resides in Arlington, Virginia with his wife and their five children.